Fangyang Wang

3.0k total citations
24 papers, 433 citations indexed

About

Fangyang Wang is a scholar working on Molecular Biology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fangyang Wang has authored 24 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Epidemiology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fangyang Wang's work include ATP Synthase and ATPases Research (5 papers), Autophagy in Disease and Therapy (4 papers) and RNA modifications and cancer (3 papers). Fangyang Wang is often cited by papers focused on ATP Synthase and ATPases Research (5 papers), Autophagy in Disease and Therapy (4 papers) and RNA modifications and cancer (3 papers). Fangyang Wang collaborates with scholars based in China, United States and Finland. Fangyang Wang's co-authors include Chunfu Wu, Jingyu Yang, Shaojie Wang, Tingjian Zhang, Jian Wang, Qi Cao, Nannan Wang, Qi Cao, Yi Li and Yating Wang and has published in prestigious journals such as Journal of Clinical Investigation, Biochemistry and Cancer Research.

In The Last Decade

Fangyang Wang

24 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangyang Wang China 11 226 71 62 56 51 24 433
Chang Gun Kim South Korea 11 412 1.8× 143 2.0× 30 0.5× 29 0.5× 19 0.4× 12 636
Chengjuan Chen China 17 281 1.2× 132 1.9× 64 1.0× 12 0.2× 74 1.5× 30 659
Qian Dong China 16 427 1.9× 61 0.9× 25 0.4× 23 0.4× 22 0.4× 35 698
Qi Huang China 16 287 1.3× 124 1.7× 24 0.4× 12 0.2× 62 1.2× 47 572
Kyung‐Min Yang South Korea 12 284 1.3× 66 0.9× 19 0.3× 22 0.4× 21 0.4× 22 413
Silvia Marchianò Italy 12 444 2.0× 65 0.9× 25 0.4× 10 0.2× 55 1.1× 30 928
Yanfei Shao China 12 228 1.0× 55 0.8× 32 0.5× 17 0.3× 20 0.4× 20 466
Lingmei Li China 15 385 1.7× 87 1.2× 40 0.6× 6 0.1× 52 1.0× 38 613
Ehsan Amin Germany 13 401 1.8× 83 1.2× 30 0.5× 10 0.2× 24 0.5× 22 609

Countries citing papers authored by Fangyang Wang

Since Specialization
Citations

This map shows the geographic impact of Fangyang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangyang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangyang Wang more than expected).

Fields of papers citing papers by Fangyang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangyang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangyang Wang. The network helps show where Fangyang Wang may publish in the future.

Co-authorship network of co-authors of Fangyang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Fangyang Wang. A scholar is included among the top collaborators of Fangyang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangyang Wang. Fangyang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
House, Nealia C., Maxine Chen, Sima Khazaei, et al.. (2025). CDK2 inhibition enhances CDK4/6 inhibitor antitumor activity in comprehensive breast cancer PDX model screen. npj Breast Cancer. 11(1). 135–135. 1 indexed citations
2.
Li, Jingchao, Fangyang Wang, Qiang Wang, et al.. (2025). Radionuclide‐Activated Luminescence for Cancer Theranostics. Chemistry - A European Journal. 31(23). e202500296–e202500296. 1 indexed citations
3.
Zhou, Weicheng, et al.. (2023). Displays of 18F-FAPI PET/CT in Myocarditis With Variable Symptom Durations. Clinical Nuclear Medicine. 48(9). 799–801. 8 indexed citations
4.
Wang, Fangyang, Ying Yang, Daniel J. Klionsky, & Sami N. Malek. (2022). Mutations in V-ATPase in follicular lymphoma activate autophagic flux creating a targetable dependency. Autophagy. 19(2). 716–719. 5 indexed citations
5.
Wang, Fangyang, et al.. (2022). Follicular lymphoma-associated mutations in the V-ATPase chaperone VMA21 activate autophagy creating a targetable dependency. Autophagy. 18(8). 1982–2000. 12 indexed citations
6.
Hu, Nan, Fangyang Wang, Tianyu Sun, et al.. (2021). Follicular Lymphoma–associated BTK Mutations are Inactivating Resulting in Augmented AKT Activation. Clinical Cancer Research. 27(8). 2301–2313. 19 indexed citations
7.
Wang, Fangyang, Damián Gatica, Luke F. Peterson, et al.. (2019). Follicular lymphoma–associated mutations in vacuolar ATPase ATP6V1B2 activate autophagic flux and mTOR. Journal of Clinical Investigation. 129(4). 1626–1640. 27 indexed citations
8.
Wang, Fangyang, Lihui Wang, Yi Li, et al.. (2017). PAC-1 and its derivative WF-210 Inhibit Angiogenesis by inhibiting VEGF/VEGFR pathway. European Journal of Pharmacology. 821. 29–38. 7 indexed citations
9.
Meng, Xiangxue, Yijia Xu, Fangyang Wang, et al.. (2017). The roles of conserved aromatic residues (Tyr5 and Tyr42) in interaction of scorpion toxin BmK AGP-SYPU1 with human Na v 1.7. International Journal of Biological Macromolecules. 99. 105–111. 10 indexed citations
10.
Wang, Fangyang, et al.. (2017). Screening and identification of a tumor specific methylation phenotype in the colorectal laterally spreading tumor.. PubMed. 21(11). 2611–2616. 4 indexed citations
11.
Li, Yi, Lihui Wang, Fangyang Wang, et al.. (2015). Copper improves the anti-angiogenic activity of disulfiram through the EGFR/Src/VEGF pathway in gliomas. Cancer Letters. 369(1). 86–96. 79 indexed citations
12.
Zhang, Tingjian, et al.. (2015). Synthesis and evaluation of 1-hydroxy/methoxy-4-methyl-2-phenyl-1H-imidazole-5-carboxylic acid derivatives as non-purine xanthine oxidase inhibitors. European Journal of Medicinal Chemistry. 103. 343–353. 70 indexed citations
13.
Meng, Xiangxue, Yijia Xu, Mingyi Zhao, et al.. (2015). The Functional Property Changes of Muscular Nav1.4 and Cardiac Nav1.5 Induced by Scorpion Toxin BmK AGP-SYPU1 Mutants Y42F and Y5F. Biochemistry. 54(19). 2988–2996. 8 indexed citations
14.
Wang, Fangyang, Yajing Liu, Lihui Wang, et al.. (2015). Targeting procaspase‐3 with WF‐208, a novel PAC‐1 derivative, causes selective cancer cell apoptosis. Journal of Cellular and Molecular Medicine. 19(8). 1916–1928. 17 indexed citations
15.
Wang, Fangyang, Lihui Wang, Yanfang Zhao, et al.. (2014). A novel small‐molecule activator of procaspase‐3 induces apoptosis in cancer cells and reduces tumor growth in human breast, liver and gallbladder cancer xenografts. Molecular Oncology. 8(8). 1640–1652. 30 indexed citations
16.
Wang, LH, Yi Li, Fangyang Wang, et al.. (2013). Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling. British Journal of Cancer. 110(2). 341–352. 93 indexed citations
17.
Han, Wenyan, Fangyang Wang, Jia Qi, et al.. (2012). NMDA receptors in the medial prefrontal cortex and the dorsal hippocampus regulate methamphetamine-induced hyperactivity and extracellular amino acid release in mice. Behavioural Brain Research. 232(1). 44–52. 16 indexed citations
18.
Wang, Fangyang, et al.. (1987). An application of knowledge engineering for fault restoration operation in secondary power systems.. IEEJ Transactions on Power and Energy. 107(10). 509–515. 6 indexed citations
19.
Wang, Fangyang, et al.. (1984). Cytogenetic study on peripheral lymphocytes in trophoblastic diseases.. PubMed. 97(4). 263–6. 1 indexed citations
20.
Wang, Fangyang, et al.. (1984). Cytogenetic study on the peripheral lymphocytes of patients with trophoblastic tumors following chemotherapy.. PubMed. 97(7). 479–82. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chang Gun Kim Breakdown of academic impact, for papers by Chengjuan Chen Breakdown of academic impact, for papers by Qian Dong Breakdown of academic impact, for papers by Qi Huang Breakdown of academic impact, for papers by Kyung‐Min Yang Breakdown of academic impact, for papers by Silvia Marchianò Breakdown of academic impact, for papers by Yanfei Shao Breakdown of academic impact, for papers by Lingmei Li Breakdown of academic impact, for papers by Ehsan Amin
Rankless by CCL
2026